About
AsymBio is a biologics CDMO based in Shanghai that provides development, manufacturing, quality control, and regulatory services for antibodies, recombinant biotherapeutics, bioconjugates, plasmids, and mRNAs. It serves global biopharmaceutical clients across early research, process development, toxicology batches, clinical batches, and commercial-scale manufacturing.
Services
Developability Assessment
Assesses developability for biologic drug candidates.
Antibodies & Recombinant Biotherapeutics
Provides cell line construction and development, upstream and downstream process development, drug substance and drug product development and manufacturing, release testing, and related services for antibodies and recombinant biotherapeutics.
CDMO: development & manufacturing
Bioconjugates
Provides payload-linker CMC services, antibody intermediate manufacturing, process development, drug product development, drug substance manufacturing, drug product manufacturing, and release testing for bioconjugates.
CDMO: development & manufacturing
mRNA
Provides plasmid linearization, in vitro mRNA transcription process development, mRNA-LNP process development, mRNA production, and mRNA release testing.
CDMO: development & manufacturing
Analytical Science & Quality Control
Provides physicochemical analysis, mass spectrometry analysis, bioassay release testing, and stability studies.
Regulatory Affairs
Provides regulatory support services for biopharmaceutical development.
- Turnaround
- 3 to 5 months lead time for IND filing package
- 7 weeks
Capabilities
- Assays and studies
- Antibodies
- Process development
- mRNA
- ADCs
- Toxicology
- LNP
8 more
- Stability studies
- Lyophilization
- Analytical development
- Physicochemical analysis
- Mass spectrometry analysis
- Bioassay release testing
- Developability assessment
- Analytical method development
- Scale and capacity
- 50+ IND projects
- 10+ NDA projects
- 30+ payload-linker projects in parallel
- 3–5 months lead time for IND filing package
- Approximately 20+ cGMP audits since 2021
Instruments and platforms
- Rigid isolators
- Reaction vessels 5–1000L
- Purification equipment
- Lyophilizer
- Nanofiltration
- Ultrafiltration
- Pressure filtration
- Rotary steaming separation and purification equipment
Modalities and species
- Modalities
- Antibody
- Bispecific
- ADC
- mRNA
- Viral vector
- Plasmid DNA
- LNP / formulation
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: passed approximately 20+ customer audits since 2021
Details
- Type
- CRDMO
- Address
- 518 Haoye Road, 4th floor, Jinshan Industrial Zone, Shanghai
- Sites
- Shanghai, China
- Serves
- Global
Public records
- Parent company
- Asymbio Holding B.V. · NL GLEIF